Sierra oncology stock yahoo finance
25 Jun 2019 Stock Research Center: This tool is the most comprehensive, go-to page on Yahoo! Finance for investors. From here, investors can click on Sierra Oncology, Inc. (SRRA) Stock Price ... - Yahoo Finance Find the latest Sierra Oncology, Inc. (SRRA) stock quote, history, news and other vital information to help you with your stock trading and investing. Sierra Oncology, Inc. (SRRA) - Yahoo Finance At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates … Sierra Oncology, Inc. (SRRA) - Yahoo Finance
Find the latest Sierra Oncology, Inc. (SRRA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Sierra Oncology (SRRA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings. Sierra Oncology has been struggling lately, but the selling pressure may be coming to an end soon. Simply Wall St. Do Institutions Own Shares In Sierra Oncology SRRA interactive stock chart | Sierra Oncology, Inc. stock ... Australian finance news, stock quotes, currency information and blogs Sierra Oncology Announces Reverse Stock Split - Yahoo Jan 22, 2020 · Sierra Oncology previously reported its cash and cash equivalents totaled $67.7 million as of September 30, 2019, and that subsequently it had closed an underwritten public offering with gross proceeds to Sierra Oncology of $103.0 million. Prior to the end of 2019, a term loan of $5.0 million was repaid to Silicon Valley Bank. About Sierra Oncology Sierra Oncology | Investor Relations - News Releases News Releases. These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below. Sierra Oncology Announces Reverse Stock Split
Sierra Oncology, Inc. (SRRA) stock price, quote ... - Yahoo
View 13F filing holders of Sierra Oncology. Netflix Weathers the Storm 03/23/ 2020; Michael Burry's Scion fund averaged down on battered Tailored Brands. View today's stock price, news and analysis for Sierra Oncology Inc. (SRRA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and Sukhi Jagpal MBA, CPAChief Financial Officer. Stock analysis for Sierra Oncology Inc (SRRA:NASDAQ GM) including stock price , stock chart, company news, key statistics, fundamentals and company profile.
Sierra Oncology is an ambitious clinical stage drug development company located in Vancouver, BC and San Francisco, CA.
1 Wall Street analysts have issued 1-year price objectives for Sierra Oncology's shares. Their forecasts range from $1.20 to $1.20. On average, they anticipate Sierra Oncology's stock price to reach $1.20 in the next twelve months. This suggests that the stock has a possible downside of 86.7%. View analysts' price targets for Sierra Oncology. Sierra Oncology, Inc. Common Stock (SRRA) Financials | Nasdaq Find the latest Financials data for Sierra Oncology, Inc. Common Stock (SRRA) at Nasdaq.com. Sierra Oncology, Inc. (SRRA) - Yahoo7 Finance Get all the key statistics for Sierra Oncology, Inc. (SRRA), including valuation measures, fiscal year financial statistics, trading records, share statistics and more.
Sierra Oncology, Inc. (SRRA) stock price, quote ... - Yahoo
At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life. Back. Sierra Oncology, Inc. (SRRA) Add to watchlist. NasdaqGM - NasdaqGM Real-time price. Currency in USD. SRRA interactive stock chart | Sierra Oncology ... - Yahoo NZ business & finance news, stock quotes, currency information and blogs. Back. Sierra Oncology, Inc. (SRRA) Add to watchlist. NasdaqGM - NasdaqGM Real-time price. Currency in USD. 9.03-0.58 (-6.04%) At close: 4:00PM EDT. This chart …
22 Jan 2020 Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused on the development and commercialization of momelotinib, 28 Jan 2020 This will be especially true if SRRA stock can build momentum from here and find a way to continue higher of off this encouraging trading View 13F filing holders of Sierra Oncology. Netflix Weathers the Storm 03/23/ 2020; Michael Burry's Scion fund averaged down on battered Tailored Brands. View today's stock price, news and analysis for Sierra Oncology Inc. (SRRA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and Sukhi Jagpal MBA, CPAChief Financial Officer. Stock analysis for Sierra Oncology Inc (SRRA:NASDAQ GM) including stock price , stock chart, company news, key statistics, fundamentals and company profile. 21 Mar 2020 Yahoo Finance is a media platform that provides financial news, data about stock quotes, press releases, and financial reports. And all the data Jan 22, 2020. Sierra Oncology Announces Reverse Stock Split. - Preferred shares issued in recently completed $103M financing to convert to common shares